The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Xu Cong Claire since 2026.
This trader's CIK number is 2114309.
At the time of last reporting, Xu Cong Claire was the SVP, Clinical Development of Novabridge Biosciences. (stock ticker symbol NBP).
Also see all insider trading activities at Novabridge Biosciences.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | NBP | 0 | $0 | 3,494 | $13,766 | 9,382 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-01 | NBP | Sale | 3,494 | 3.94 | 13,766 |
| 2026-05-30 | NBP | Option Ex | 9,382 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Xu Cong Claire (SVP, Clinical Development of Novabridge Biosciences at the time of this reporting) see the Securities and Exchange Commission (SEC) website.